# Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma

> **NCT05867004** · — · RECRUITING · sponsor: **Institut Claudius Regaud** · enrollment: 100 (estimated)

## Conditions studied

- Melanoma
- Immune Defect
- Tumor Skin

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05867004
- **Lead sponsor:** Institut Claudius Regaud
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-01
- **Primary completion:** 2025-07-03
- **Final completion:** 2026-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05867004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05867004, "Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05867004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*